Changes in T cell receptor excision DNA circle (TREC) levels in HIV type 1-infected subjects pre- and post-highly active antiretroviral therapy.

The T cell receptor excision DNA circle (TREC) level is an independent predictor of HIV-1 disease prognosis. We studied the temporal changes in TREC levels prior to and after highly active antiretroviral therapy (HAART) in a cohort of 131 Greek men with hemophilia who were followed up for up to 20 years since seroconversion (SC). TREC levels were determined in all available cryopreserved samples of peripheral blood mononuclear cells (PBMCs) using a multiplex real-time polymerase chain reaction (PCR) assay. Trends in log(10) TREC values were described using random effects models. Prior to HAART initiation TREC levels tended to decrease over time (mean rate of drop 19% per year; 95% CI: 16-22%). Initial TREC values were higher with younger age at SC, but the subsequent rate of drop did not differ significantly by age at SC. There was a monotonic relationship between baseline HIV-RNA levels and TREC slopes with steeper slopes at higher levels of HIV-RNA. The TREC slopes differed significantly by clinical outcome being steeper in subjects who progressed to AIDS sooner. After HAART initiation, TREC values tended to increase on average by 35% per year (95% CI: -7-94%) but the increase was evident only in subjects with a pre-HAART CD4 count below 80 cells/microl. TREC values, which likely represent a simple indicator of naive T-lymphocyte reserve, may be a clinically useful marker for long-term prognosis of HIV-1 infection and for immune reconstitution after successful HAART.

[1]  Alan S. Perelson,et al.  Dynamics of T Cells and TCR Excision Circles Differ After Treatment of Acute and Chronic HIV Infection1 2 , 2002, The Journal of Immunology.

[2]  E. Ruiz-Mateos,et al.  Evidence of thymic function in heavily antiretroviral-treated human immunodeficiency virus type 1-infected adults with long-term virologic treatment failure. , 2002, The Journal of infectious diseases.

[3]  N. Klein,et al.  Increased thymic output after initiation of antiretroviral therapy in human immunodeficiency virus type 1-infected children in the Paediatric European Network for Treatment of AIDS (PENTA) 5 Trial. , 2002, The Journal of infectious diseases.

[4]  M. Leal,et al.  T-cell repopulation and thymic volume in HIV-1-infected adult patients after highly active antiretroviral therapy. , 2002, Blood.

[5]  S. Pocock,et al.  Impact of Missing Data Due to Selective Dropouts in Cohort Studies and Clinical Trials , 2002, Epidemiology.

[6]  C. Giaquinto,et al.  Immune reconstitution in HIV-1-infected children on antiretroviral therapy: role of thymic output and viral fitness , 2002, AIDS.

[7]  R. Manfredi.  HIV Disease and Advanced Age , 2002, Drugs & aging.

[8]  Daniel C. Douek,et al.  Evidence for Increased T Cell Turnover and Decreased Thymic Output in HIV Infection1 , 2001, The Journal of Immunology.

[9]  H. Hooijkaas,et al.  Therapeutic immune reconstitution in HIV-1-infected children is independent of their age and pretreatment immune status , 2001, AIDS.

[10]  S. Pahwa,et al.  Evaluation of T cell receptor gene rearrangement excision circles after antiretroviral therapy in children infected with human immunodeficiency virus. , 2001, The Journal of infectious diseases.

[11]  M. Wellons,et al.  Immunologic profile of human immunodeficiency virus-infected patients during viral remission and relapse on antiretroviral therapy. , 2001, The Journal of infectious diseases.

[12]  P. Schneider,et al.  Discordant increases in CD4+ T cells in human immunodeficiency virus-infected patients experiencing virologic treatment failure: role of changes in thymic output and T cell death. , 2001, The Journal of infectious diseases.

[13]  H. Schuitemaker,et al.  T cell depletion in HIV-1 infection: how CD4+ T cells go out of stock , 2000, Nature Immunology.

[14]  Rob J. de Boer,et al.  Increased cell division but not thymic dysfunction rapidly affects the T-cell receptor excision circle content of the naive T cell population in HIV-1 infection , 2000, Nature Medicine.

[15]  B. Haynes,et al.  Thymic function after hematopoietic stem-cell transplantation for the treatment of severe combined immunodeficiency. , 2000, The New England journal of medicine.

[16]  Giota Touloumi,et al.  Effect of recent thymic emigrants on progression of HIV-1 disease , 2000, The Lancet.

[17]  H. Schuitemaker,et al.  In vivo HIV-1 infection of CD45RA(+)CD4(+) T cells is established primarily by syncytium-inducing variants and correlates with the rate of CD4(+) T cell decline. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[18]  B. Haynes,et al.  The role of the thymus in immune reconstitution in aging, bone marrow transplantation, and HIV-1 infection. , 2000, Annual review of immunology.

[19]  Paul Palumbo,et al.  Measuring Recent Thymic Emigrants in Blood of Normal and HIV-1–Infected Individuals before and after Effective Therapy , 1999, The Journal of experimental medicine.

[20]  S J Pocock,et al.  Estimation and comparison of rates of change in longitudinal studies with informative drop-outs. , 1999, Statistics in medicine.

[21]  M. Clerici,et al.  Thymus volume correlates with the progression of vertical HIV infection. , 1999, AIDS.

[22]  J V Giorgi,et al.  Shorter survival in advanced human immunodeficiency virus type 1 infection is more closely associated with T lymphocyte activation than with plasma virus burden or virus chemokine coreceptor usage. , 1999, The Journal of infectious diseases.

[23]  B. Haynes,et al.  The human thymus , 1998 .

[24]  Louis J. Picker,et al.  Changes in thymic function with age and during the treatment of HIV infection , 1998, Nature.

[25]  J. Goedert,et al.  Effects of age at seroconversion and baseline HIV RNA level on the loss of CD4+ cells among persons with hemophilia , 1998, AIDS.

[26]  A. Hatzakis,et al.  Determinants of progression of HIV infection in a Greek hemophilia cohort followed for up to 16 years after seroconversion. , 1998, Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association.

[27]  R. Grant,et al.  High prevalence of thymic tissue in adults with human immunodeficiency virus-1 infection. , 1998, The Journal of clinical investigation.

[28]  B. Haynes,et al.  The human thymus , 1998, Immunologic research.

[29]  J. Zack,et al.  Mechanism of human immunodeficiency virus type 1 localization in CD4-negative thymocytes: differentiation from a CD4-positive precursor allows productive infection , 1997, Journal of virology.

[30]  D. Ho,et al.  Rapid-high, syncytium-inducing isolates of human immunodeficiency virus type 1 induce cytopathicity in the human thymus of the SCID-hu mouse , 1994, Journal of virology.

[31]  J. Sprent,et al.  Turnover of Naive-and Memory-phenotype T Cells , 1994 .

[32]  J. McCune,et al.  HIV induces thymus depletion in vivo , 1993, Nature.

[33]  Kaizhai Shen,et al.  CD4 , 1990 .

[34]  K. Bailey,et al.  Analysing changes in the presence of informative right censoring caused by death and withdrawal. , 1988, Statistics in medicine.

[35]  J. Goedert,et al.  Natural history of human immunodeficiency virus infections in hemophiliacs: effects of T-cell subsets, platelet counts, and age. , 1987, Annals of internal medicine.